UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cutaneous melanoma

The Lancet (British edition), 2014-03, Vol.383 (9919), p.816-827

2014

Volltextzugriff (PDF)

Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3810-3818

2012

Volltextzugriff (PDF)

Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2413-2420

2013

Volltextzugriff (PDF)

Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1562-1571

2024

Volltextzugriff (PDF)

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3831-3837

2013

Volltextzugriff (PDF)

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-10, Vol.160, p.127-135

2021

Volltextzugriff (PDF)

Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective

Current oncology (Toronto), 2023-10, Vol.30 (11), p.9660-9669

2023

Volltextzugriff (PDF)

Genetic and morphologic features for melanoma classification

Pigment cell and melanoma research, 2010-12, Vol.23 (6), p.763-770

2010

Volltextzugriff (PDF)

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8677-8685

2022

Volltextzugriff (PDF)

Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1328-1337

2020

Volltextzugriff (PDF)

A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4443

2022

Volltextzugriff (PDF)

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

Current oncology (Toronto), 2022-02, Vol.29 (2), p.1107-1116

2022

Volltextzugriff (PDF)

Maximizing confidence in a negative result: Quantitative sample adequacy control

Journal of infection and public health, 2020-07, Vol.13 (7), p.991-993

2020

Volltextzugriff (PDF)

Importance of Adequate qPCR Controls in Infection Control

Diagnostics (Basel), 2021-12, Vol.11 (12), p.2373

2021

Volltextzugriff (PDF)

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

Journal for immunotherapy of cancer, 2017-11, Vol.5 (1), p.83-83, Article 83

2017

Volltextzugriff (PDF)

Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre

Cancer treatment and research communications, 2023, Vol.35, p.100696-100696, Article 100696

2023

Volltextzugriff (PDF)

Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction Monitoring

ACS pharmacology & translational science, 2020-12, Vol.3 (6), p.1304-1309

2020

Volltextzugriff (PDF)

Gene expression profiling of human angiotropic primary melanoma: Selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis

European journal of cancer (1990), 2011-05, Vol.47 (8), p.1267-1275

2011

Volltextzugriff (PDF)

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC

Oncotarget, 2018-10, Vol.9 (84), p.35472-35473

2018

Volltextzugriff (PDF)

Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas

Cancer treatment and research communications, 2021, Vol.29, p.100484-100484, Article 100484

2021

Volltextzugriff (PDF)

Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy

Human pathology, 2014-10, Vol.45 (10), p.2006-2013

2014

Volltextzugriff (PDF)

Sex influence on cancer immunotherapy efficacy and safety in advanced non-small cell lung cancer (NSCLC): A Canadian institution real-world experience

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e20618-e20618

2024

Volltextzugriff (PDF)

A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9579-9579

2023

Volltextzugriff (PDF)

The impact of COVID-19 on the survival outcome of lung cancer at a Canadian academic centre: A real-world data analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21200-e21200

2023

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(122)

Sprache

Englisch
(122)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cutaneous melanoma

Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer

Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective

Genetic and morphologic features for melanoma classification

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center

Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC

A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

Maximizing confidence in a negative result: Quantitative sample adequacy control

Importance of Adequate qPCR Controls in Infection Control

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine

Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre

Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction Monitoring

Gene expression profiling of human angiotropic primary melanoma: Selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC

Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas

Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy

Sex influence on cancer immunotherapy efficacy and safety in advanced non-small cell lung cancer (NSCLC): A Canadian institution real-world experience

A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results

The impact of COVID-19 on the survival outcome of lung cancer at a Canadian academic centre: A real-world data analysis

Suchergebnisse filtern